Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 9;20(1):331.
doi: 10.1186/s13019-025-03369-y.

Perceval prosthesis implantation into challenging degenerated aortic valves: a literature review and case series

Pouya Nezafati  1 , Chimezi Uchime  2 , Sumit Yadav  3   4
Affiliations
Review

Perceval prosthesis implantation into challenging degenerated aortic valves: a literature review and case series

Pouya Nezafati et al. J Cardiothorac Surg. .

Abstract

Background: The Perceval Sutureless prosthesis can increase the effective orifice area (EOA) and reduce the chance of prosthesis-patient mismatch (PPM). This report presents three patients with challenging degenerated bioprosthetic valves undergoing redo aortic valve replacement (rAVR) using the Perceval (LivaNova, London, UK) prosthesis from a cohort of more than 300 performed cases and a review of the literature on the management of challenging degenerated valves.

Methods: Case 1: Degenerated 23 mm Trifecta with the valve cage densely adherent to the annulus. Cage with sewing ring were excised and annulus sized to a large Perceval valve. Case 2: Degenerated 29 mm Epic from a Bentall's procedure. Calcified and rigid prosthetic leaflets as well as stent posts were excised and XL Perceval implanted. Case 3: Degenerated 27 mm Epic with signs of endocarditis from a history of Bentall's procedure. Three calcified leaflets of the Epic valve were completely excised. The orifice accepted a medium Perceval.

Results: The total Cardiopulmonary Bypass (CPB) and aortic cross clamp (ACC) times (in minutes) were 99.76, 117.68 and 143.99 in Cases 1, 2 and 3, respectively. Moreover, post-implantation transesophageal echocardiogram (TOE) demonstrated a well-seated valve, no paravalvular leak in all cases and a peak gradient of 12.7 mmHg, 14.8 mmHg and 17.7 mmHg in Cases 1, 2 and 3, respectively.

Conclusion: The Perceval prosthesis is an excellent choice for rAVR, as it can safely simplify challenging cases at risk of PPM and is an excellent valve-in-valve alternative to degenerated or infected Bentall valves with patent graft. The Perceval prosthesis can be well seated on the different structures of a degenerated bioprosthetic valve.

Keywords: Aortic valve replacement; Degenerated aortic valve; Perceval.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Written informed consent was obtained from all participants. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
(a) Stepwise complete excision of Trifecta valve (b) Large Perceval Implanted onto the annulus
Fig. 2
Fig. 2
(a) Excision of Epic stent posts from a Valsalva graft (b) X-Large Perceval implanted onto the Valsalva graft
Fig. 3
Fig. 3
(a) Excision of Epic Leaflets and placement of stay sutures (b) Implantation of Medium Perceval onto Stent posts
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Jones JM, O’Kane H, Gladstone DJ, Sarsam MA, Campalani G, MacGowan SW, Cleland J, Cran GW. Repeat heart valve surgery: risk factors for operative mortality. J Thorac Cardiovasc Surg. 2001;122:913–8. - PubMed
    1. Kostyunin AE, Yuzhalin AE, Rezvova MA, Ovcharenko EA, Glushkova TV, Kutikhin AG. Degeneration of bioprosthetic heart valves: update 2020. J Am Heart Assoc. 2020;9:e018506. - PMC - PubMed
    1. Dhanekula A, Nishath T, Aldea G, Burke CR. Surgical and non-surgical sutureless aortic valve replacement are minimally invasive options for the management of degenerated bioprosthetic valves. JTCVS Tech 2022 Feb 26:13:31–9. - PMC - PubMed
    1. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA Guideline for the management of patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation. 2021;143(5):e35–71. - PubMed
    1. Tarantini G, Dvir D, Tang GH. Transcatheter aortic valve implantation in degenerated surgical aortic valves. EuroIntervention. 2021;17(9):709–19. - PMC - PubMed

LinkOut - more resources